Skip to main content
Caplight Logo









Lucida Medical

Lucida Medical

Private
CambridgeHealthcare & Life Scienceshttps://lucidamedical.com/

Last Round

Early Funding

Mar 30, 2026

Total Funding Raised

$14.72M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Lucida Medical is a healthtech company that develops artificial intelligence-based software to assist clinicians in detecting and diagnosing cancer using MRI scans.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

prostate cancer detectionmedical imaging AIradiology softwareprostate MRImedtechAI diagnosticsclinical decision supporthealthtechmedical device softwareradiology AISaaSclinical workflowAI radiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucida Medical Comparables

Compare Lucida Medical with similar companies based on industry and business-model similarity.

Lucida Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FUSE-AI
91%
Bot Image, Inc.
89%
mediaire
82%

Lucida Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 30, 2026
GrantJul 9, 2024
GrantFeb 12, 2024
SeedMar 19, 2021

Key People

Founding team and executive leadership

Antony Rix

CEO and Co-Founder

Founding Team

Lucida Medical Investors

Notable investors and investment history

Lucida Medical investors
InvestorRounds
SBRI HealthcareGrant
IW CapitalEarly Funding
Prostate Cancer ResearchSeed
NHS Accelerated Access CollaborativeGrant
XTX VenturesEarly Funding, Seed
Macmillan Cancer SupportEarly Funding, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 17% QoQ, from 29 to 34 employees.

  • Apr 15, 2026

    Monthly visitors increased 42% to 7,000.

Lucida Medical Filings

Explore SEC and related filing metadata, where available.

Lucida Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lucida Medical's valuation, stock price, and market status.

Is Lucida Medical a public or private company?

Lucida Medical is a private company.

What is the current stock price of Lucida Medical?

Lucida Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Lucida Medical worth (valuation)?

Valuation information for Lucida Medical is not publicly available.

Can I buy Lucida Medical stock?

Lucida Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lucida Medical's last funding round?

Lucida Medical's most recent funding round was Early Funding on March 30, 2026.

Who are the main investors in Lucida Medical?

Key investors in Lucida Medical include IW Capital, Prostate Cancer Research, XTX Ventures.

Will Lucida Medical IPO soon?

No public IPO plans have been announced for Lucida Medical.

How can I track Lucida Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lucida Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range28
Year Founded2019
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?